Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis

Blood

Volumn 92, Issue 10, 1998, Pages 3694-3700

  Nierodzik, Mary Lynn ^b   Chen, Kui ^b   Takeshita, Kenichi ^b   Li, Jian Jun ^b   Huang, Yao Qi ^b   Feng, Xue Sheng ^b   D'Andrea, Michael R ^b   Andrade Gordon, Patricia ^b   Karpatkin, Simon ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; GLYCOPROTEIN IB; PROTEINASE; RECEPTOR; THROMBIN; THROMBIN RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032533268     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.10.3694     Document Type: Article

References (40)

1. Nierodzik ML, Plotkin A, Kajumo F, Karpatkin S: Thrombin stimulates adhesion of tumor cells to platelets. Requirement of GPIIb/ GPIIIa and an RGD-dependent mechanism. J Clin Invest 87:229, 1991
2. Nierodzik ML, Kajumo F, Karpatkin S: Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and metastasis in vivo. Cancer Res 52:3267, 1992
3. Wojtukiewicz MZ, Tang DG, Ciarelli JJ, Nelson KK, Walz DA, Diglio CA, Mammen EF, Honn KV: Thrombin increases the metastatic potential of tumor cells. Intl J Cancer 54:793, 1993
4. Wojtukiewicz MZ, Tang DC, Ben-Josef E, Renaud C, Walz DA, Honn KV: Solid tumor cells express functional tethered ligand thrombin receptor. Cancer Res 55:698, 1995
5. Klepfish A, Greco MA, Karpatkin S: Thrombin stimulates tumor cell binding to endothelial cells and subendothelial matrix. Intl J Cancer 53:983, 1993
6. Vu T-KH, Hung DT, Wheaton VI, Coughlin SR: Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057, 1991
7. + mobilization. FEBS Lett 288:123, 1991
8. Nierodzik ML, Bain MR, Liu L-X, Shivji M, Takeshita K, Karpatkin S: Presence of the seven transmembrane thrombin receptor on human tumor cells: Effect of activation on tumor adhesion to platelets and tumor tyrosine phosphorylation. Br J Haematol 92:452, 1996
9. Ngaiza JR, Jaffe EA: A 14 amino acid peptide derived from the amino terminus of the cleaved thrombin receptor elevates intracellular calcium and stimulates prostacyclin production in human endothelial cells. Biochem Biophys Res Commun 179:1656, 1991
10. Vassallo RR, Kieber-Emmons T, Chichowski K, Brass LF: Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. J Biol Chem 27:6081, 1992
11. Zhong C, Hayzer DJ, Corson M, Runge MS: Molecular cloning of the rat smooth muscle thrombin receptor: Evidence for in vitro regulation by basic fibroblast growth factor. J Biol Chem 267:16975, 1992
12. Yamamoto N, Greco NJ, Barnard MR, Tanoue K, Yamazaki H, Jamieson GA, Michelson AD: GPIb-dependent and GPIb-independent pathways of thrombin-induced platelet activation. Blood 77:1740, 1991
13. Gralnick HR, Williams S, McKeown LP, Hansmann K: High affinity alpha-thrombin binding to platelet glycoprotein Ib alpha: Identification of two binding domains. Proc Natl Acad Sci USA 91:6334, 1994
14. Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YWZ, Timmons C, Tram T, Coughlin SR: Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386:502, 1997
15. Pearlstein E, Ambrogio C, Karpatkin S: Effect of anti-platelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma. Lewis lung carcinoma and B16 amelanotic melanoma tumor cells in mice. Cancer Res 44:3884, 1984
16. Karpatkin S, Pearlstein E, Ambrogio C, Coller BS: Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J Clin Invest 81:1012, 1988
17. Pearlstein E, Ambrogio C, Gasic G, Karpatkin S: Inhibition of the platelet aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine-N-(-3-ethy1-1,5-pentanediyl)amide. Cancer Res 41: 4535, 1981
18. Goldfarb M, Deed R, MacAllan D, Walther W, Dickson C, Peters G: Cell transformation by Int-2, a member of the fibroblast growth factor family. Oncogene 6:65, 1991
19. D'Andrea MR, Derian CK, Leturcq D, Baker SM, Brunmark A, Ling P, Darrow AL, Santulli RJ, Brass LF, Andrade-Gordon P: Characterization of protease activated receptor (PAR-2) immunoreactivity in normal human tissues. J Histochem Cytochem 46:1, 1998
20. Chen LB, Buchanan JM: Mitogenic activity of blood components. I. Thrombin and prothrombin. Proc Natl Acad Sci USA 72:131, 1975
21. Carney DH, Glenn KC, Cunningham DD: Conditions which affect initiation of animal cell division by trypsin and thrombin. J Cell Physiol 95:13, 1978
22. Glenn KC, Carney DH, Fenton JW, Cunningham DD: Thrombin active site regions required for fibroblast receptor binding and initiation of cell division. J Biol Chem 255:6609, 1980
23. Carney DH, Stiernberg J, Fenton JW: Initiation of proliferative events by human α-thrombin requires both receptor binding and enzymic activity. J Cell Biochem 26:181, 1984
24. Morris DL, Ward JB Jr, Carney DH: Thrombin promotes cell transformation in Balb 3T3/A 31-1-13 cells. Carcinogenesis (London) 13:67, 1992
25. McNamara CA, Sarembok U, Gimple LW: Thrombin stimulation of smooth muscle cell proliferation is mediated by a proteolytic, receptor-mediated mechanism. J Clin Invest 91:94, 1992
26. Yoshida E, Verrusio EN, Mihara H, Oh D, Kwaan HC: Enhancement of the expression of urokinase-type plasminogen activator from PC-3 human prostate cancer cells by thrombin. Cancer Res 54:3300, 1984
27. Yu H, Schulz RM: Relationship between secreted urokinase plasminogen activator and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes. Cancer Res 50:7623, 1990
28. Hearing VJ, Law LW, Corti A, Appella E, Blasi F: Modulation of metastatic potential by cell surface urokinase of murine melanoma cells. Cancer Res 48:1270, 1988
29. ++ dependent mechanism. Blood 76:1173, 1990
30. Trejo J, Chambard JC, Karin M, Brown JH: Biphasic increase in c-jun mRNA is required for induction of AP-1 -mediated gene transcription: Differential effects of muscarinic and thrombin receptor activation. Mol Cell Biol 12:4742, 1992
31. Trejo J-A, Connolly AJ, Coughlin SR: The cloned thrombin receptor is necessary and sufficient for activation of mitogen-activated protein kinase and mitogenesis in mouse lung fibroblasts. J Biol Chem 271:21536, 1996
32. Honn KV, Sloane BF, Cavanaugh PG: Role of the coagulation system in tumor-cell-induced platelet aggregation and metastasis. Haemostasis 18:37, 1988
33. Fisher EG, Ruf W, Mueller BM: Tissue factor-initiated thrombin generation activates the signaling thrombin receptor on malignant melanoma cells. Cancer Res 55:1629, 1995
34. Mueller BM, Reisfeld RA, Edgington TS, Ruf W: Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci USA 89:11832, 1992
35. Bromberg ME, Konigsberg WH, Madison JF, Pacoashe A, Garen A: Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci USA 92:8205, 1995
36. Zacharski LR, Memoli VA, Morain WD, Schlaeppi J-M, Rousseau SM: Cellular localization of enzymatically-active thrombin in intact tissue by hirudin binding. Thromb Haemost 73:793, 1995
37. Merskey C, Johnson AJ, Harris JU, Want MT, Swain S: Isolation of fibrinogen-fibrin related antigen from human plasma by immuneaffinity chromatography: Its characterization in normal subjects and in defibrinating patients with abruptio placentae and disseminated cancer. Br J Haematol 44:655, 1980
38. Peuscher FW, Cleton FJ, Armstrong L, Stoepman van Dalen EA, van Aken WG: Significance of plasma fibrinopeptide A (FPA) in patients with malignancy. J Lab Clin Med 96:5, 1980
39. Yoda Y, Abe T: Fibrinopeptide A (FPA) level and fibrinogen Kinetics in patients with malignant disease. Thromb Haemost 46:706, 1981
40. Rickles FR, Edwards RC, Barb C, Cronlund M: Abnormalities of blood coagulation in patients with cancer: fibrinopeptide A generation and tumor growth. Cancer 51:301, 1983